Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope.
about
Characteristics of the Clostridium difficile cell envelope and its importance in therapeuticsThe potential for emerging therapeutic options for Clostridium difficile infectionMultivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycansA Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionCompetition between serum IgG, IgM, and IgA anti-glycan antibodiesChemical synthesis of the outer core oligosaccharide of Escherichia coli R3 and immunological evaluation.Vaccines against Clostridium difficile.Synthetic Glycan Microarrays.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.Total syntheses of five uvacalols: structural validation of uvacalol A, uvacalol B and uvacalol C and disproval of the structures of uvacalol E and uvacalol G.Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine.Total Synthesis of Five Lipoteichoic acids of Clostridium difficile.Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.Bio-inspired synthesis of rare and unnatural carbohydrates and cyclitols through strain driven epimerization.Potential targets for next generation anti-microbial glycoconjugate vaccines.Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.
P2860
Q26745652-6628A6D3-1B32-4F14-A19B-AA7E63D15688Q28082059-4D4962EB-28A0-4BFF-9E1A-45252C44D037Q28834483-61874976-E8F2-4310-AC5A-01DF6B5F18BAQ30240264-35B4F3A7-2AF9-4CC1-97A8-7BD7A1543DBAQ35217313-16A3BB9A-2E54-4C5E-9B9B-06627BB4BAC1Q35783024-44142A69-B7E4-47CB-AEBD-27EFF2B6B314Q38196682-ED097E8C-60E9-4392-8666-7A6DF24090EEQ38290082-21B0FD94-CD1D-4F7F-A1F0-FCAAADBECF07Q39093233-43597055-E711-45A1-BE78-EB71B9BA996BQ41472936-5FC55265-7D80-4AB1-9FC9-7E6CC90F8E67Q42710354-8332AF6E-BC0C-49CE-8D36-7D16A74D6AE3Q46846094-3FCB9EC5-A817-4199-97C9-0A18E132E435Q47707104-7E3317AA-C6C1-4A63-8B55-180BC3982A50Q51746050-7D874404-0EF1-49B0-AE47-2FD5FDBF7C11Q53701548-1C4798FD-8CE6-4C3B-B455-E0DBB1C234B9Q55194285-A866EB8D-02C3-428C-A05A-7D0557C159EF
P2860
Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Immunological evaluation of a ...... fication of a minimal epitope.
@en
Immunological evaluation of a ...... fication of a minimal epitope.
@nl
type
label
Immunological evaluation of a ...... fication of a minimal epitope.
@en
Immunological evaluation of a ...... fication of a minimal epitope.
@nl
prefLabel
Immunological evaluation of a ...... fication of a minimal epitope.
@en
Immunological evaluation of a ...... fication of a minimal epitope.
@nl
P2093
P921
P356
P1476
Immunological evaluation of a ...... fication of a minimal epitope.
@en
P2093
Chakkumkal Anish
Christopher E Martin
Felix Broecker
Jochen Mattner
Julia Komor
Matthias A Oberli
Peter H Seeberger
P304
P356
10.1021/JA401410Y
P407
P577
2013-06-24T00:00:00Z